Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
With the invention of the Geiger gaseous ionization detector in 1913, which became the Geiger-Müller gaseous ionization detector in 1928 - named after the physicists Hans Geiger (1882-1945) and Walther Müller (1905-1979) - the individual particles or quanta of ionizing radiation could be detected and measured. Detectors developed later, such as proportional counters or scintillation counters, which not only "count" but also measure energy and distinguish between types of radiation, also became important for radiation protection. Scintillation measurement is one of the oldest methods of detecting ionizing radiation or X-rays; originally, a zinc sulfide screen was held in the path of the beam and the scintillation events were either counted as flashes or, in the case of X-ray diagnostics, viewed as an image. A scintillation counter known as a spinthariscope was developed in 1903 by William Crookes (1832-1919) and used by Ernest Rutherford (1871-1937) to study the scattering of alpha particles from atomic nuclei.
== Proteomic profiling in disease detection == Proteomics profiling has been used in the discovery of biomarkers for diseases. A study conducted with the use of the Olink Proteomics Platform found that patients with glaucoma had differently expressed metabolic proteins, thus the potential of proteomics in early disease detection and development of a therapeutic strategy.
Sugar was first produced from sugar cane in the Indian subcontinent. Diverse species of sugar cane seem to have originated from India (Saccharum barberi and S. edule) and New Guinea (S. officinarum). Sugarcane is described in Chinese manuscripts dating to the 8th century BCE, which state that the use of sugarcane originated in India. Nearchus (admiral of Alexander the Great), the Greek physician Pedanius Dioscorides and the Roman Pliny the Elder also described sugar. In the mid-15th century, sugar was introduced into Madeira and the Canary Islands, where it was mass-produced. Christopher Columbus introduced it to the New World, leading to sugar industries in Cuba and Jamaica by the 1520s. The Portuguese took sugar cane to Brazil. Beet sugar, the starting point for the modern sugar industry, was a German invention. Beet sugar was first produced industrially in 1801 in Cunern, Prussia. Sugar became a household item by the 19th century, and this evolution of taste and demand for sugar as an essential food ingredient resulted in major economic and social changes. Demand drove, in part, the colonisation and industrialisation of previously under-developed lands. It was also intimately associated with slavery. World consumption increased more than 100 times from 1850 to 2000, led by the United Kingdom, where it increased from about 2 pounds per head per year in 1650 to 90 pounds by the early 20th century.
=== March === 3 March – The GMB and Unison unions have called off ambulance strikes in England scheduled for 6 and 8 March after the UK government agrees to reopen talks on pay for the 2022–23 and 2023–24 financial years. Following a trial at Luton Crown Court, four people are jailed for their part in a robbery that went wrong during which their victim, Saul Murray, was stabbed after being given the drug GHB in an attempt to knock him out. Ikem Affia is sentenced to life imprisonment for murder, with a minimum of 25 years, while the three other gang members are given lesser sentences for manslaughter. The gang were caught after one of them was captured on CCTV wearing a rare Moncler coat worth £1,000, of which only 69 had been sold in the UK. 5 March – The Unite union calls off ambulance strikes scheduled for 6 and 8 March. 8 March – The National Institute for Health and Care Excellence (NICE) approves the use of the weight loss drug semaglutide (marketed as Wegovy) by the NHS in England. 13 March – The Unite union calls off a planned strike by bus drivers at National Express West Midlands scheduled for 16 March after receiving a revised pay offer, which is to be put to members. 16 March – NHS staff in England, including nurses and ambulance staff, are offered a 5% pay rise from April along with a one-off payment of £1,655 to cover backdated pay. The offer does not include doctors, who are on a different contract.
Sources: en.wikipedia.org
In the Autonomous Province of Kosovo and Metohija, a growing desire for independence emerged among the Albanian majority population. Already, an unrecognised Republic of Kosova had emerged with underground institutions. In 1996, the Kosovo Liberation Army, an Albanian militia promoting Kosovar independence, launched attacks against Serbian police stations, killing at least ten Serbian policemen in direct attacks between 1996 and 1998. The low level insurgency eventually escalated. After Slobodan Milošević was elected President of Yugoslavia in 1997, having served his maximum two terms as President of Serbia, he ordered Yugoslav Army (VJ) units to move into Kosovo to aid in the suppression of the insurrection. The governments of the FR Yugoslavia and the US declared the Kosovo Liberation Army a terrorist organisation, following repeated deadly attacks against Yugoslav law enforcement agencies. US intelligence also mentioned illegal arms sources of the Kosovo Liberation Army, including conducting raids during the course of the 1997 Albanian civil unrest, and drug dealing. Despite this, substantial evidence now shows that the CIA had aided in training units of the KLA, although not necessarily providing them with arms and funding. In 1998, the Kosovo War began, following increased open combat with Yugoslav police and army units deployed by Milošević. The KLA found itself heavily outnumbered and outgunned in open combat, and had to use guerrilla tactics.
Inspection focuses on the face and particularly on the tongue, including analysis of the tongue size, shape, tension, color and coating, and the absence or presence of teeth marks around the edge. Auscultation refers to listening for particular sounds (such as wheezing). Olfaction refers to attending to body odor. Inquiry focuses on the "seven inquiries", which involve asking the person about the regularity, severity, or other characteristics of: chills, fever, perspiration, appetite, thirst, taste, defecation, urination, pain, sleep, menses, leukorrhea. Palpation which includes feeling the body for tender A-shi points, and the palpation of the wrist pulses as well as various other pulses, and palpation of the abdomen.
Feasting was central to the culture. By the 10th century, dining shifted from reclining to tables with clean linen. The introduction of the fork and salad dressing (with oil and vinegar) further shaped Italian and Western traditions. Classical Greco-Roman era foods were common such as the condiment garos (similar to fermented fish sauces today) as well as the still popular baklava. Fruits like aubergine and orange, unknown during classical times, were added to diets. Foods that have continued into the modern era include the cured meat paston, Feta cheese, salt roe similar to the modern boutargue, Black sea caviar, tiropita, dolmades, and the soup trachanas. There were famed medieval sweet wines such as the Malvasia from Monemvasia, the Commandaria, and the eponymous Rumney wine which were drunk, as were millet beer (known as boza) and retsina.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.